Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 229

1.

Comprehensive Transcriptome Profiling of Cryptic CBFA2T3-GLIS2 Fusion-positive AML Defines Novel Therapeutic Options - A COG and TARGET Pediatric AML Study.

Smith JL, Ries RE, Hylkema T, Alonzo TA, Gerbing RB, Santaguida MT, Eidenschink Brodersen L, Pardo L, Cummings CL, Loeb KR, Le Q, Imren S, Leonti AR, Gamis AS, Aplenc R, Kolb EA, Farrar JE, Triche TJ, Nguyen C, Meerzaman D, Loken MR, Oehler VG, Bolouri H, Meshinchi S.

Clin Cancer Res. 2019 Nov 12. pii: clincanres.1800.2019. doi: 10.1158/1078-0432.CCR-19-1800. [Epub ahead of print]

PMID:
31719049
2.

RNAIndel: discovering somatic coding indels from tumor RNA-Seq data.

Hagiwara K, Ding L, Edmonson MN, Rice SV, Newman S, Easton J, Dai J, Meshinchi S, Ries RE, Rusch M, Zhang J.

Bioinformatics. 2019 Oct 8. pii: btz753. doi: 10.1093/bioinformatics/btz753. [Epub ahead of print]

PMID:
31593214
3.

MALDI-TOF Mass Spectrometry-Based High-Throughput Screening for Inhibitors of the Cytosolic DNA Sensor cGAS.

Simon RP, Winter M, Kleiner C, Ries R, Schnapp G, Heimann A, Li J, Zuvela-Jelaska L, Bretschneider T, Luippold AH, Reindl W, Bischoff D, Büttner FH.

SLAS Discov. 2019 Oct 4:2472555219880185. doi: 10.1177/2472555219880185. [Epub ahead of print]

PMID:
31583948
4.

Reading, writing and erasing mRNA methylation.

Zaccara S, Ries RJ, Jaffrey SR.

Nat Rev Mol Cell Biol. 2019 Oct;20(10):608-624. doi: 10.1038/s41580-019-0168-5. Epub 2019 Sep 13. Review.

PMID:
31520073
5.

m6A enhances the phase separation potential of mRNA.

Ries RJ, Zaccara S, Klein P, Olarerin-George A, Namkoong S, Pickering BF, Patil DP, Kwak H, Lee JH, Jaffrey SR.

Nature. 2019 Jul;571(7765):424-428. doi: 10.1038/s41586-019-1374-1. Epub 2019 Jul 10.

PMID:
31292544
6.

Functional Properties of KIT Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia.

Tarlock K, Alonzo TA, Wang YC, Gerbing RB, Ries R, Loken MR, Pardo L, Hylkema T, Joaquin J, Sarukkai L, Raimondi SC, Hirsch B, Sung L, Aplenc R, Bernstein I, Gamis AS, Meshinchi S, Pollard JA.

Clin Cancer Res. 2019 Aug 15;25(16):5038-5048. doi: 10.1158/1078-0432.CCR-18-1897. Epub 2019 Jun 10.

PMID:
31182436
7.

Chemical Derivatization Enables MALDI-TOF-Based High-Throughput Screening for Microbial Trimethylamine (TMA)-Lyase Inhibitors.

Winter M, Bretschneider T, Thamm S, Kleiner C, Grabowski D, Chandler S, Ries R, Kley JT, Fowler D, Bartlett C, Binetti R, Broadwater J, Luippold AH, Bischoff D, Büttner FH.

SLAS Discov. 2019 Aug;24(7):766-777. doi: 10.1177/2472555219838216. Epub 2019 May 6.

PMID:
31059309
8.

Genomic subtyping and therapeutic targeting of acute erythroleukemia.

Iacobucci I, Wen J, Meggendorfer M, Choi JK, Shi L, Pounds SB, Carmichael CL, Masih KE, Morris SM, Lindsley RC, Janke LJ, Alexander TB, Song G, Qu C, Li Y, Payne-Turner D, Tomizawa D, Kiyokawa N, Valentine M, Valentine V, Basso G, Locatelli F, Enemark EJ, Kham SKY, Yeoh AEJ, Ma X, Zhou X, Sioson E, Rusch M, Ries RE, Stieglitz E, Hunger SP, Wei AH, To LB, Lewis ID, D'Andrea RJ, Kile BT, Brown AL, Scott HS, Hahn CN, Marlton P, Pei D, Cheng C, Loh ML, Ebert BL, Meshinchi S, Haferlach T, Mullighan CG.

Nat Genet. 2019 Apr;51(4):694-704. doi: 10.1038/s41588-019-0375-1. Epub 2019 Mar 29.

9.

Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia.

McNeer NA, Philip J, Geiger H, Ries RE, Lavallée VP, Walsh M, Shah M, Arora K, Emde AK, Robine N, Alonzo TA, Kolb EA, Gamis AS, Smith M, Gerhard DS, Guidry-Auvil J, Meshinchi S, Kentsis A.

Leukemia. 2019 Aug;33(8):1934-1943. doi: 10.1038/s41375-019-0402-3. Epub 2019 Feb 13.

10.

Effect of Augmenting Standard Care for Military Personnel With Brief Caring Text Messages for Suicide Prevention: A Randomized Clinical Trial.

Comtois KA, Kerbrat AH, DeCou CR, Atkins DC, Majeres JJ, Baker JC, Ries RK.

JAMA Psychiatry. 2019 May 1;76(5):474-483. doi: 10.1001/jamapsychiatry.2018.4530.

PMID:
30758491
11.

Publisher Correction: The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions.

Bolouri H, Farrar JE, Triche T Jr, Ries RE, Lim EL, Alonzo TA, Ma Y, Moore R, Mungall AJ, Marra MA, Zhang J, Ma X, Liu Y, Liu Y, Auvil JMG, Davidsen TM, Gesuwan P, Hermida LC, Salhia B, Capone S, Ramsingh G, Zwaan CM, Noort S, Piccolo SR, Kolb EA, Gamis AS, Smith MA, Gerhard DS, Meshinchi S.

Nat Med. 2019 Mar;25(3):530. doi: 10.1038/s41591-019-0369-7.

PMID:
30705421
12.

Perspectives on a contingency management intervention for alcohol use among consumers with serious mental illness.

Leickly E, Skalisky J, Angelo FA, Srebnik D, McPherson S, Roll JM, Ries RK, McDonell MG.

Psychiatr Rehabil J. 2019 Mar;42(1):26-31. doi: 10.1037/prj0000330. Epub 2018 Nov 26.

PMID:
30475006
13.

Formative, multimethod case studies of learn to quit, an acceptance and commitment therapy smoking cessation app designed for people with serious mental illness.

Vilardaga R, Rizo J, Ries RK, Kientz JA, Ziedonis DM, Hernandez K, McClernon FJ.

Transl Behav Med. 2018 Nov 16. doi: 10.1093/tbm/iby097. [Epub ahead of print]

PMID:
30445507
14.

Contingency management intervention targeting co-addiction of alcohol and drugs among American Indian adults: Design, methodology, and baseline data.

Burduli E, Skalisky J, Hirchak K, Orr MF, Foote A, Granbois A, Ries R, Roll JM, Buchwald D, McDonell MG, McPherson SM.

Clin Trials. 2018 Dec;15(6):587-599. doi: 10.1177/1740774518796151. Epub 2018 Aug 29.

PMID:
30156433
15.

Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group.

Noort S, Zimmermann M, Reinhardt D, Cuccuini W, Pigazzi M, Smith J, Ries RE, Alonzo TA, Hirsch B, Tomizawa D, Locatelli F, Gruber TA, Raimondi S, Sonneveld E, Cheuk DK, Dworzak M, Stary J, Abrahamsson J, Arad-Cohen N, Czogala M, De Moerloose B, Hasle H, Meshinchi S, van den Heuvel-Eibrink M, Zwaan CM.

Blood. 2018 Oct 11;132(15):1584-1592. doi: 10.1182/blood-2018-05-849059. Epub 2018 Aug 27.

16.

Automated MALDI Target Preparation Concept: Providing Ultra-High-Throughput Mass Spectrometry-Based Screening for Drug Discovery.

Winter M, Ries R, Kleiner C, Bischoff D, Luippold AH, Bretschneider T, Büttner FH.

SLAS Technol. 2019 Apr;24(2):209-221. doi: 10.1177/2472630318791981. Epub 2018 Aug 3.

PMID:
30074850
17.

Serious Mental Illness in Heavy Drinkers Is Associated with Poor Treatment Outcomes in Outpatients with Co-occurring Disorders.

Oluwoye O, Leickly E, Skalisky J, McPherson S, Hirchak K, Srebnik D, Roll JM, Ries RK, McDonell MG.

Int J Ment Health Addict. 2018 Jun;16(3):672-679. Epub 2017 Oct 31.

18.

Distinct age-associated molecular profiles in acute myeloid leukemia defined by comprehensive clinical genomic profiling.

Tarlock K, Zhong S, He Y, Ries R, Severson E, Bailey M, Morley S, Balasubramanian S, Erlich R, Lipson D, Otto GA, Vergillo JA, Kolb EA, Ross JS, Mughal T, Stephens PJ, Miller V, Meshinchi S, He J.

Oncotarget. 2018 May 29;9(41):26417-26430. doi: 10.18632/oncotarget.25443. eCollection 2018 May 29.

19.

Change in anxiety sensitivity and substance use coping motives as putative mediators of treatment efficacy among substance users.

Wolitzky-Taylor K, Drazdowski TK, Niles A, Roy-Byrne P, Ries R, Rawson R, Craske MG.

Behav Res Ther. 2018 Aug;107:34-41. doi: 10.1016/j.brat.2018.05.010. Epub 2018 May 24.

PMID:
29852309
20.

Who needs more than standard care? Treatment moderators in a randomized clinical trial comparing addiction treatment alone to addiction treatment plus anxiety disorder treatment for comorbid anxiety and substance use disorders.

Wolitzky-Taylor K, Niles AN, Ries R, Krull JL, Rawson R, Roy-Byrne P, Craske M.

Behav Res Ther. 2018 Aug;107:1-9. doi: 10.1016/j.brat.2018.05.005. Epub 2018 May 17.

PMID:
29800622
21.

Using a randomized controlled trial to test whether modifications to contingency management improve outcomes for heavy drinkers with serious mental illness.

Oluwoye O, Skalisky J, Burduli E, Chaytor NS, McPherson S, Murphy SM, Herron J, Hirchak K, Burley M, Ries RK, Roll JM, McDonell MG.

Contemp Clin Trials. 2018 Jun;69:92-98. doi: 10.1016/j.cct.2018.04.010. Epub 2018 Apr 20.

22.

Erratum: The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions.

Bolouri H, Farrar JE, Triche T Jr, Ries RE, Lim EL, Alonzo TA, Ma Y, Moore R, Mungall AJ, Marra MA, Zhang J, Ma X, Liu Y, Liu Y, Auvil JMG, Davidsen TM, Gesuwan P, Hermida LC, Salhia B, Capone S, Ramsingh G, Zwaan CM, Noort S, Piccolo SR, Kolb EA, Gamis AS, Smith MA, Gerhard DS, Meshinchi S.

Nat Med. 2018 Apr 10;24(4):526. doi: 10.1038/nm0418-526b.

PMID:
29634680
23.

Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours.

Ma X, Liu Y, Liu Y, Alexandrov LB, Edmonson MN, Gawad C, Zhou X, Li Y, Rusch MC, Easton J, Huether R, Gonzalez-Pena V, Wilkinson MR, Hermida LC, Davis S, Sioson E, Pounds S, Cao X, Ries RE, Wang Z, Chen X, Dong L, Diskin SJ, Smith MA, Guidry Auvil JM, Meltzer PS, Lau CC, Perlman EJ, Maris JM, Meshinchi S, Hunger SP, Gerhard DS, Zhang J.

Nature. 2018 Mar 15;555(7696):371-376. doi: 10.1038/nature25795. Epub 2018 Feb 28.

24.

Establishing MALDI-TOF as Versatile Drug Discovery Readout to Dissect the PTP1B Enzymatic Reaction.

Winter M, Bretschneider T, Kleiner C, Ries R, Hehn JP, Redemann N, Luippold AH, Bischoff D, Büttner FH.

SLAS Discov. 2018 Jul;23(6):561-573. doi: 10.1177/2472555218759267. Epub 2018 Feb 21.

PMID:
29466676
25.

User-Centered Design of Learn to Quit, a Smoking Cessation Smartphone App for People With Serious Mental Illness.

Vilardaga R, Rizo J, Zeng E, Kientz JA, Ries R, Otis C, Hernandez K.

JMIR Serious Games. 2018 Jan 16;6(1):e2. doi: 10.2196/games.8881.

26.

Randomized clinical trial evaluating the preliminary effectiveness of an integrated anxiety disorder treatment in substance use disorder specialty clinics.

Wolitzky-Taylor K, Krull J, Rawson R, Roy-Byrne P, Ries R, Craske MG.

J Consult Clin Psychol. 2018 Jan;86(1):81-88. doi: 10.1037/ccp0000276.

27.

The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions.

Bolouri H, Farrar JE, Triche T Jr, Ries RE, Lim EL, Alonzo TA, Ma Y, Moore R, Mungall AJ, Marra MA, Zhang J, Ma X, Liu Y, Liu Y, Auvil JMG, Davidsen TM, Gesuwan P, Hermida LC, Salhia B, Capone S, Ramsingh G, Zwaan CM, Noort S, Piccolo SR, Kolb EA, Gamis AS, Smith MA, Gerhard DS, Meshinchi S.

Nat Med. 2018 Jan;24(1):103-112. doi: 10.1038/nm.4439. Epub 2017 Dec 11. Erratum in: Nat Med. 2018 Apr 10;24(4):526. Nat Med. 2019 Mar;25(3):530.

28.

Interaction between pre-treatment drug use and heterogeneity of psychiatric diagnosis predicts outcomes in outpatients with co-occurring disorders.

Oluwoye O, Hirchak K, Leickly E, Skalisky J, McPherson S, Srebnik D, Roll JM, Ries RK, McDonell MG.

Psychiatry Res. 2018 Feb;260:233-235. doi: 10.1016/j.psychres.2017.11.070. Epub 2017 Nov 29.

29.

Homelessness predicts attrition but not alcohol abstinence in outpatients experiencing co-occurring alcohol dependence and serious mental illness.

Leickly E, Skalisky J, Oluwoye O, McPherson SM, Srebnik D, Roll JM, Ries RK, McDonell MG.

Subst Abus. 2018;39(3):271-274. doi: 10.1080/08897077.2017.1391926. Epub 2017 Dec 8.

30.

MicroRNA Expression-Based Model Indicates Event-Free Survival in Pediatric Acute Myeloid Leukemia.

Lim EL, Trinh DL, Ries RE, Wang J, Gerbing RB, Ma Y, Topham J, Hughes M, Pleasance E, Mungall AJ, Moore R, Zhao Y, Aplenc R, Sung L, Kolb EA, Gamis A, Smith M, Gerhard DS, Alonzo TA, Meshinchi S, Marra MA.

J Clin Oncol. 2017 Dec 10;35(35):3964-3977. doi: 10.1200/JCO.2017.74.7451. Epub 2017 Oct 25. Erratum in: J Clin Oncol. 2019 Jan 20;37(3):261.

31.

Mental Health Professionals' Suicide Risk Assessment and Management Practices.

Roush JF, Brown SL, Jahn DR, Mitchell SM, Taylor NJ, Quinnett P, Ries R.

Crisis. 2018 Jan;39(1):55-64. doi: 10.1027/0227-5910/a000478. Epub 2017 Sep 15.

32.

Prevalence and Correlates of Cannabis Use in Outpatients with Serious Mental Illness Receiving Treatment for Alcohol Use Disorders.

Skalisky J, Leickly E, Oluwoye O, McPherson SM, Srebnik D, Roll JM, Ries RK, McDonell MG.

Cannabis Cannabinoid Res. 2017 Jun 1;2(1):133-138. doi: 10.1089/can.2017.0006. eCollection 2017.

33.

Pretreatment ethyl glucuronide levels predict response to a contingency management intervention for alcohol use disorders among adults with serious mental illness.

McDonell MG, Leickly E, McPherson S, Skalisky J, Hirchak K, Oluwoye O, Srebnik D, Roll JM, Ries RK.

Am J Addict. 2017 Oct;26(7):673-675. doi: 10.1111/ajad.12558. Epub 2017 Aug 18.

34.

Irx1 regulates dental outer enamel epithelial and lung alveolar type II epithelial differentiation.

Yu W, Li X, Eliason S, Romero-Bustillos M, Ries RJ, Cao H, Amendt BA.

Dev Biol. 2017 Sep 1;429(1):44-55. doi: 10.1016/j.ydbio.2017.07.011. Epub 2017 Jul 23.

35.

Inhibition of the miR-17-92 Cluster Separates Stages of Palatogenesis.

Ries RJ, Yu W, Holton N, Cao H, Amendt BA.

J Dent Res. 2017 Oct;96(11):1257-1264. doi: 10.1177/0022034517716915. Epub 2017 Jun 29.

36.

CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531.

Lamba JK, Chauhan L, Shin M, Loken MR, Pollard JA, Wang YC, Ries RE, Aplenc R, Hirsch BA, Raimondi SC, Walter RB, Bernstein ID, Gamis AS, Alonzo TA, Meshinchi S.

J Clin Oncol. 2017 Aug 10;35(23):2674-2682. doi: 10.1200/JCO.2016.71.2513. Epub 2017 Jun 23.

37.

Response to Urine Drug Testing in a Family Residency Practice.

McDonell MG, West II, Ries RK, Donovan DM, Bumgardner K, Dunn C, Atkins DC, Roy-Byrne P, Maynard C.

J Addict Med. 2017 May/Jun;11(3):243. doi: 10.1097/ADM.0000000000000283. No abstract available. Erratum in: J Addict Med. 2018 Nov/Dec;12(6):501.

38.

Genomic architecture and treatment outcome in pediatric acute myeloid leukemia: a Children's Oncology Group report.

Vujkovic M, Attiyeh EF, Ries RE, Goodman EK, Ding Y, Kavcic M, Alonzo TA, Wang YC, Gerbing RB, Sung L, Hirsch B, Raimondi S, Gamis AS, Meshinchi S, Aplenc R.

Blood. 2017 Jun 8;129(23):3051-3058. doi: 10.1182/blood-2017-03-772384. Epub 2017 Apr 14.

39.

Prediction of Suicide Ideation and Attempt Among Substance-Using Patients in Primary Care.

Hallgren KA, Ries RK, Atkins DC, Bumgardner K, Roy-Byrne P.

J Am Board Fam Med. 2017 Mar-Apr;30(2):150-160. doi: 10.3122/jabfm.2017.02.160264.

40.

A Randomized Controlled Trial of Ethyl Glucuronide-Based Contingency Management for Outpatients With Co-Occurring Alcohol Use Disorders and Serious Mental Illness.

McDonell MG, Leickly E, McPherson S, Skalisky J, Srebnik D, Angelo F, Vilardaga R, Nepom JR, Roll JM, Ries RK.

Am J Psychiatry. 2017 Apr 1;174(4):370-377. doi: 10.1176/appi.ajp.2016.16050627. Epub 2017 Jan 31. Erratum in: Am J Psychiatry. 2017 Jun 1;174(6):604.

41.

Disease Characteristics and Prognostic Implications of Cell-Surface FLT3 Receptor (CD135) Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group.

Tarlock K, Alonzo TA, Loken MR, Gerbing RB, Ries RE, Aplenc R, Sung L, Raimondi SC, Hirsch BA, Kahwash SB, McKenney A, Kolb EA, Gamis AS, Meshinchi S.

Clin Cancer Res. 2017 Jul 15;23(14):3649-3656. doi: 10.1158/1078-0432.CCR-16-2353. Epub 2017 Jan 20.

42.

Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.

Laszlo GS, Alonzo TA, Gudgeon CJ, Harrington KH, Kentsis A, Gerbing RB, Wang YC, Ries RE, Raimondi SC, Hirsch BA, Gamis AS, Meshinchi S, Walter RB.

J Hematol Oncol. 2016 Nov 30;9(1):133. No abstract available.

43.

Assessment and Treatment of Adolescent Substance Use Disorders: Alcohol Use Disorders.

Margret CP, Ries RK.

Child Adolesc Psychiatr Clin N Am. 2016 Jul;25(3):411-30. doi: 10.1016/j.chc.2016.03.008. Review.

PMID:
27338964
44.

Expression and functional characterization of CD33 transcript variants in human acute myeloid leukemia.

Laszlo GS, Harrington KH, Gudgeon CJ, Beddoe ME, Fitzgibbon MP, Ries RE, Lamba JK, McIntosh MW, Meshinchi S, Walter RB.

Oncotarget. 2016 Jul 12;7(28):43281-43294. doi: 10.18632/oncotarget.9674.

45.

Utility of Point-of-care Urine Drug Tests in the Treatment of Primary Care Patients With Drug Use Disorders.

McDonell MG, Graves MC, West II, Ries RK, Donovan DM, Bumgardner K, Krupski A, Dunn C, Maynard C, Atkins DC, Roy-Byrne P.

J Addict Med. 2016 May-Jun;10(3):196-201. doi: 10.1097/ADM.0000000000000220.

46.

CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML.

Maxson JE, Ries RE, Wang YC, Gerbing RB, Kolb EA, Thompson SL, Guidry Auvil JM, Marra MA, Ma Y, Zong Z, Mungall AJ, Moore R, Long W, Gesuwan P, Davidsen TM, Hermida LC, Hughes SB, Farrar JE, Radich JP, Smith MA, Gerhard DS, Gamis AS, Alonzo TA, Meshinchi S.

Blood. 2016 Jun 16;127(24):3094-8. doi: 10.1182/blood-2016-04-709899. Epub 2016 May 3. No abstract available. Erratum in: Blood. 2017 Jan 5;129(1):134.

47.

Genomic Profiling of Pediatric Acute Myeloid Leukemia Reveals a Changing Mutational Landscape from Disease Diagnosis to Relapse.

Farrar JE, Schuback HL, Ries RE, Wai D, Hampton OA, Trevino LR, Alonzo TA, Guidry Auvil JM, Davidsen TM, Gesuwan P, Hermida L, Muzny DM, Dewal N, Rustagi N, Lewis LR, Gamis AS, Wheeler DA, Smith MA, Gerhard DS, Meshinchi S.

Cancer Res. 2016 Apr 15;76(8):2197-205. doi: 10.1158/0008-5472.CAN-15-1015. Epub 2016 Mar 3.

48.

Suicide risk and associated demographic and clinical correlates among primary care patients with recent drug use.

Carmel A, Ries R, West II, Bumgardner K, Roy-Byrne P.

Am J Drug Alcohol Abuse. 2016 May;42(3):351-7. doi: 10.3109/00952990.2015.1133634. Epub 2016 Feb 24.

49.

A culturally-tailored behavioral intervention trial for alcohol use disorders in three American Indian communities: Rationale, design, and methods.

McDonell MG, Nepom JR, Leickly E, Suchy-Dicey A, Hirchak K, Echo-Hawk A, Schwartz SM, Calhoun D, Donovan D, Roll J, Ries R, Buchwald D.

Contemp Clin Trials. 2016 Mar;47:93-100. doi: 10.1016/j.cct.2015.12.010. Epub 2015 Dec 17.

50.

User Experience Evaluation of a Smoking Cessation App in People With Serious Mental Illness.

Vilardaga R, Rizo J, Kientz JA, McDonell MG, Ries RK, Sobel K.

Nicotine Tob Res. 2016 May;18(5):1032-8. doi: 10.1093/ntr/ntv256. Epub 2015 Nov 17.

Supplemental Content

Support Center